Flucloxacillin

6 trials 4 recruiting JAnti-infectives

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

4 Recruiting

0 Completed trials

6 Sponsors

7 Countries

Phase III

Phase III/IV

Phase IV

Phase III: 2 Phase III/IV: 1 Phase IV: 3

Sponsors using this IMP

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) 1 Friedrich-Schiller-Universitaet Jena 1 Hvidovre Hospital 1 Pirkanmaan hyvinvointialue 1 University Medical Center Utrecht 1 UZ Leuven 1

All trials

6 total

LIBRETTO: Stimulan™ Local Antibiotic Delivery System Versus 4-Week Systemic Antibiotic Therapy for Diabetic Foot Osteomyelitis – A Prospecti… Pending

2025-524723-52-00 Phase III 1 country Pirkanmaan hyvinvointialue
Efficacy and safety of Dalbavancin in the treatment of infective Endocarditis caused by gram-positive cocci Pending

2026-526149-91-00 Phase III 1 country Friedrich-Schiller-Universitaet Jena
Rapid Oral Switch in Infectious Endocarditis, the ROSIE study Recruiting

2025-524484-20-00 Phase IV 1 country UZ Leuven
Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, no… Recruiting

2024-519186-21-01 Phase IV 1 country Hvidovre Hospital
BuLLSEYE Recruiting

2024-512950-13-00 Phase III/IV 1 country Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Staphylococcus aureus Network Adaptive Platform trial (SNAP) Recruiting

2023-503582-35-00 Phase IV 4 countries University Medical Center Utrecht

Showing 1–6 of 6 trials

← All drugs A–Z